These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 8731235

  • 1. Influence of severity of chronic inflammatory joint disease on the pharmacokinetics of indomethacin and etodolac.
    Pawlotsky Y, Le Dantec P, Jacquelinet C, Lapicque F, Goasguen J, Perdriger A, Veillard E, Guggenbuhl P, Netter P.
    Rev Rhum Engl Ed; 1996 Mar; 63(3):179-87. PubMed ID: 8731235
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic difference between S-(+)- and R-(-)-etodolac in rats.
    Shi JM, Lai SG, Xu CJ, Duan GL, Li D.
    Acta Pharmacol Sin; 2004 Aug; 25(8):996-9. PubMed ID: 15301730
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic interactions of concomitant administration of febuxostat and NSAIDs.
    Khosravan R, Wu JT, Joseph-Ridge N, Vernillet L.
    J Clin Pharmacol; 2006 Aug; 46(8):855-66. PubMed ID: 16855070
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of etodolac in the horse following oral and intravenous administration.
    Davis JL, Papich MG, Morton AJ, Gayle J, Blikslager AT, Campbell NB.
    J Vet Pharmacol Ther; 2007 Feb; 30(1):43-8. PubMed ID: 17217400
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of etodolac in patients with stable juvenile rheumatoid arthritis.
    Boni JP, Korth-Bradley JM, Martin P, Simcoe DK, Richards LS, Rennebohm R, Walson PD.
    Clin Ther; 1999 Oct; 21(10):1715-24. PubMed ID: 10566567
    [Abstract] [Full Text] [Related]

  • 9. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial.
    Bahrami H, Daryani NE, Haghpanah B, Moayyeri A, Moghadam KF, Mirmomen S, Kamangar F.
    Am J Gastroenterol; 2005 Apr; 100(4):856-61. PubMed ID: 15784032
    [Abstract] [Full Text] [Related]

  • 10. Relationships between the concentrations of prostaglandins and the nonsteroidal antiinflammatory drugs indomethacin, diclofenac, and ibuprofen.
    Giagoudakis G, Markantonis SL.
    Pharmacotherapy; 2005 Jan; 25(1):18-25. PubMed ID: 15767216
    [Abstract] [Full Text] [Related]

  • 11. Double-blind, randomised, comparative trial of etodolac SR versus diclofenac in the treatment of osteoarthritis of the knee.
    Liang TH, Hsu PN.
    Curr Med Res Opin; 2003 Jan; 19(4):336-41. PubMed ID: 12841927
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A double-blind, randomized, controlled parallel group study evaluating the efficacy and safety of acemetacin for the management of osteoarthritis.
    Chou CT, Tsai YY.
    Int J Clin Pharmacol Res; 2002 Jan; 22(1):1-6. PubMed ID: 12395912
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
    Furst DE, Saag K, Fleischmann MR, Sherrer Y, Block JA, Schnitzer T, Rutstein J, Baldassare A, Kaine J, Calabrese L, Dietz F, Sack M, Senter RG, Wiesenhutter C, Schiff M, Stein CM, Satoi Y, Matsumoto A, Caldwell J, Harris RE, Moreland LW, Hurd E, Yocum D, Stamler DA.
    Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of etodolac on gait in hip osteoarthritis as assessed by Bessou's locometer: a randomized, crossover, double-blind study versus placebo. Groupe de Recherche sur le Handicap de L'appareil Locomoteur.
    Mejjad O, Favre S, Dujardin F, Thomine J, Le Loët X, Weber J.
    Osteoarthritis Cartilage; 2000 May; 8(3):230-5. PubMed ID: 10806051
    [Abstract] [Full Text] [Related]

  • 17. A prospective randomized trial of topical soluble 0.1% indomethacin versus 0.1% diclofenac versus placebo for the control of pain following excimer laser photorefractive keratectomy.
    Assouline M, Renard G, Arne JL, David T, Lasmolles C, Malecaze F, Pouliquen YJ.
    Ophthalmic Surg Lasers; 1998 May; 29(5):365-74. PubMed ID: 9599360
    [Abstract] [Full Text] [Related]

  • 18. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.
    Maksymowych WP, Jhangri GS, Fitzgerald AA, LeClercq S, Chiu P, Yan A, Skeith KJ, Aaron SL, Homik J, Davis P, Sholter D, Russell AS.
    Arthritis Rheum; 2002 Mar; 46(3):766-73. PubMed ID: 11920413
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of etodolac in aged patients affected by degenerative joint disease (osteoarthritis) in its active phase.
    Todesco S, Del Ross T, Marigliano V, Ariani A.
    Int J Clin Pharmacol Res; 1994 Mar; 14(1):11-26. PubMed ID: 7927957
    [Abstract] [Full Text] [Related]

  • 20. The effectiveness of prophylactic etodolac on postendodontic pain.
    Menke ER, Jackson CR, Bagby MD, Tracy TS.
    J Endod; 2000 Dec; 26(12):712-5. PubMed ID: 11471639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.